Renal Sympathetic Denervation in Patients with Resistant Hypertension: A Feasibility Study.

ABSTRACT:

Background/aims

We assessed the feasibility of renal sympathetic denervation (RDN) treatment in patients with resistant hypertension using the Iberis® RDN system. This study was a prospective, multicenter, single-arm feasibility registry.

Methods

We collected data from patients who underwent RDN treatment using the Iberis system. From November 2014 to February 2016, 16 patients from 6 centers in Europe were enrolled in this registry.

Results

Consistent reductions in the 24-h systolic blood pressure (SBP) and diastolic blood pressure were obtained. At any follow-up point, more than 70% of the patients were responders. The change in the 24-h SBP at 1 month was strongly correlated with that at 12 months.

Conclusion

The Iberis system is safe and effective in patien

SUBMITTER: Kario K 

PROVIDER: S-EPMC6489090 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature